April 2017 | Manchester Health & Care Commissioning

MHCC Board Meeting April 2017

Date: Wednesday 5 April
Time: 1.30pm - 5.15pm
Venue: Windrush Millennium Centre, 70 Alexandra Road, Moss Side, Manchester, M16 7WD

No.	Item	Lead /Speaker	Time
1	MEETING OPEN Welcome and Apologies	Chair	1.30pm
1.1	Public Questions	Chair	1.35pm
1.2	Public / Patient Story	Manchester People First	1.40pm
1.3	Agenda Briefing	Director of Corporate Affairs	2pm
1.4	Minutes, matters arising and declarations of interest	Chair	2.05pm
1.5	Chair and Chief Accountable Officer Update	Chair/ CAO	2.10pm
2	ESTABLISHMENT OF MANCHESTER HEALTH AND CARE COMMISSIONING
2.1	NHS Manchester CCG Constitution	Director of Corporate Affairs	2.20pm
2.2	Committees terms of reference	Director of Corporate Affairs	2.30pm
2.2.1	Clinical committee terms of reference
2.2.2	Finance committee terms of reference
2.2.3	Governance committee terms of reference
2.2.4	Executive committee terms of reference
2.2.5	Quality and performance committee terms of reference
2.2.6	Patient and Public Advisory Group terms of reference
2.3	Partnership Agreement	Director of Corporate Affairs	2.40pm
2.4	NHS England Primary Medical Services Delegation Agreement	Director of Corporate Affairs	2.50pm
3	STRATEGY
3.1	Manchester Health and Care Commissioning Strategy	Chair / Director of Planning and Operations	3pm
4	DELIVERY
4.1	Operational Plan	Clinical Director / Director of Planning and Operations	3.15pm
4.1	MHCC operational plan Word
4.1	MHCC operational plan Powerpoint
4.1	MHCC operational plan Excel
4.2	Finance report	Chief Finance Officer	3.30pm
4.2	Opening budgets
4.3	Quality and Performance report	Director of Quality and Performance	3.45pm
4.4	Engagement	Lay Representative for Patient and Public Involvement	4pm
4.5	Organisational development	Director of Workforce & OD	4.15pm
5	ASSURANCE
5.1	Risk management	Director of Corporate Affairs	4.30pm
6	ITEMS FOR INFORMATION
6.1	Board forward plan	Chair	4.40pm
7	MEETING CLOSE Chair's remarks	Chair	5.10pm
7.1	Resolution to exclude representatives of the media and members of the public from the remainder of the meeting (due to the confidential nature of the business to be transacted).